- Release Date: 02/12/20 09:08
- Summary: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
- Price Sensitive: Yes
- Download Document 116.21KB
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
-
- There are more pages in this discussion • 572 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
-0.005(0.44%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.12 | $1.166M | 1.027M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 59092 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 16812 | 7 |
View Market Depth
| Last trade - 10.29am 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |